Hypocomplementemia is an extremely complex phenomenon: wedevoted our attention to its immunogenetic basis, particularly to the HLA haplotypes involved and to the study of C4 polymorphic genes. With this in mind we analyzed a group of unrelated patients with hypocomplementemia and 15 families suffering from specific C4 deficiency. Firstly, we performed a population analysis in order to identify a statistically significant association: HLA-B35 and C4BQOalleles, in the total group ofhypocomplementemic individuals, seem to be associated with the primary disease. Secondly, we defined HLA haplotypes clear-cut segregation in the hypocomplementemic families and we identified the most common HLA haplotypes carrying B35 and C4 null allele associated with this condition. With the aid of correspondence analysis and the Transmission Disequilibrium Test (TDT), we measured the strength of this association. In this work, mainly through family analysis, we envisaged a potentially interesting genomic trait, within HLA, close to B locus, that seems to be involved in hypocomplementemia itself and perhaps in hypocomplementemia-related disorders.
The HLA class III complement gene cluster coding for C2, Factor B (Bf), C4A and C4B has always raised particular interest due to observed associations with diseases (1-2); however, the strong linkage disequilibrium with other HLA alleles often makes it difficult to identify true candidate genes. The complement gene cluster has evolved into two independent tandem duplications, one coding for the serine proteases involved in the alternative pathway eC2 and Bf), and the other comprising the C4 locus coding for the RP1, C4, CYP 21 and TNX genes called the RCCX module (3) . In fact, the presence of the tandemly duplicated RCCX modules has given rise to a complex structural polymorphism involving segmental duplications and deletions of the two isotypic C4 genes. This is further complicated by the fact that C4 genetic deficiency might also be based on gene conversion or point mutation events that can cause non-expression of C4 genes at the proteinic level (3) . There are diseases, such as systemic lupus erythematosus (SLE), that are correlated with particular deficiencies of complement system components. But it is important to distinguish the causes that lead to these deficiencies: great consumption rather than insufficient, or absent, production of complement proteins. Great consumption is determined, in most cases, by the complement activation induced by extrinsic infectious agents or by autoantibodies that first activate the complement classic pathway with severe consumption of complement cascade components. Alternatively the insufficient or absent production of complement proteins can be determined by diseases reducing the function of organs specifically involved in the synthesis of complement proteins (i.e. hepatitis) or by genetic causes such as homozygous presence of C4AQO or C4BQO null alleles (4) .
It is proposed that the severity of genetic hypocomplementemia is associated not only with the number of C4 null alleles but also with other genetic factors that are not yet identified.
C4 protein plays an important role in the activation of the complement classic pathways because of its interaction with other initial components: since C4A and C4B present fundamentally different amino acid sequences, the binding affinity of each interaction depends on the sequence ofthe C4 molecule: so the deficiency of one of these two genes should have differing clinical consequences.
At the same time, immunocomplexes clearance by complement and phagocytosis depends on C3 and C4 binding to cellular aggregates and on the presence of C3 and C4 receptors on macrophages and phagocytes (5) .
The clinical, biochemical and immunogenetic features of hypo complementemia are an extremely complex phenomenon which suggests the involvement of more than one gene in its etiology. With this in mind, we studied 39 among 315 followed-up unrelated patients and 15 families in order to search for a possible association of primary and secondary hypocomplementemia with HLA haplotypes and complotypes. C4 Polymorphism. Samples of serum were conserved in EDT A, treated with carboxipeptidase and neuroaminidase and electrophoresed onto agarose gel with high voltage. The allelic proteinic bands were underlinedafter immunofixationwith polyclonal antibodies anti-human C4 and Blue Comassie painting (6, 7) .
MATERIALS AND METHODS

Western blotting
When it was hard to distinguish between C4 A slow variants and C4 B speed alleles, after electrophoresis, proteins were transferred on nitrocellulose filter and hybridised with monoclonal antibodies anti-C4 A and anti-C4 B (Clonab anti-C4A, anti-C4B, Biotest). The use of a second antibody (goat IgG anti-murine IgG) binding a cromophore (3-amino-9-etylcarbozole) allows the visualization of the allelic bands (8) .
Bftyping
For Bf allele typing we have used electrophoresis onto agarose gel followed by immunofixation with antibodies anti-human Factor B (Atlantic Antibodies, Scarborough, ME) (9) .
Densitometric analysis
Densitometric analysis of all electrophoretic bands was performed to recognize silent alleles (C4AQO and C4BQO) of C4 proteins and to discriminate between homo and heteroduplications. Using a BIO-PROFIL program, every electrophoretic pattern corresponds on the graphic to a gaussian area, directly proportional to band intensity. Examining the number of gaussians, it is possible to establish the number of alleles, the null alleles and the duplications (l0).
Statistical analysis
Gene frequency comparisons were made by X 2 or Fisher exact test, as appropriate. In order to represent graphically the relationship between the serological categories and HLA alleles, a correspondence analysis was also performed by means of SIMCA2 program. Correspondence analysis is a multivariate statistical technique that displays each category in a scatterplot; their relative position in this map indicates certain levels of association between them. The total inertia that summarizes the overall differences between points is broken down into components for each ofthe principal axes.
Transmission disequilibrium test (TDT) was applied to verify if, in affected pedigree members, the inheritance of some "susceptibility" alleles or haplotypes was more or less than the expected 50% according to Mendelian rules (11) .
A two point linkage analysis was performed applying a model of dominant disease with prevalence about 2-3% by means of LINKAGE program. For different recombination fraction (q), likelihood functions L(q) were compared to that relative to the independence of the markers (12), i.e, L(q=0.5), and evaluated by means of Morton's LOD Score:
RESULTS
a) Population analysis
In this work we analyzed 315 unrelated individuals: 39 out of these were classified as hypocomplementemic, following analysis. Among hypocomplementemic patients, 4 were affected by SLE (Systemic Lupus Erythematosus), 3 by RA (rheumatoid arthritis), 2 by scleroderma, 5 by HBV and HCV (viral B or C hepatitis), 4 by hypogammaglobulinemia, 2 by multiple myeloma;
Tab.I. Allele From our studies, HLA-B35, HLA-B51, HLA-B8, C4AQO, and C4BQO were the alleles with the frequencies deviated from the control. In particular HLA-B35 was the allele whose frequency was altered the most (29.5% compared with 13.6% of the control, p=O.OOI). The frequency of C4BQO was 23.7% compared with 11.7% of the control (p<O.OI). The frequency of HLA-B8 was 10.2% compared with 5.7% ofthe control. The frequency of HLA-B51 was 11.5% compared with 9.8% of the control (see Tab.l). However, only HLA-B35 and C4BQO deviations raised a statistical significance.
We subdivided the hypocomplementemic individuals (n=39) in three groups with the aim of searching for a relationship between clinical phenotypes and HLA alleles. In particular, we studied 3 groups: the first group included all the hypocomplementemic individuals affected by a)HLA-A3.CW3,B62.DR4,DQ8 b)HLA-A2,CW4,B35,DR 14,005 hepatic diseases (different hepatic disorders and HBV/HCV infections); the second group included hypocomplementemic individuals with diseases other than hepatic ones; the third group included individuals with hypocomplementemia with no secondary diseases. We analyzed the variation of the HLA allelic frequencies in the different groups and some interesting differences were found (Tab.2). The frequency of HLA-B35 was generally increased. C4BQOwas particularly over-represented in patients with true primary hypocomplementemia without associated immunopathologies. C4AQOand HLA-B8 showed the highest frequency in hepatopatic patients and HLA-B51 was under-represented in the hypocomplementemic probands without secondary immune diseases.
The correspondence analysis results are plotted in Fig 1. The first principal axis, which accounts for the 49.4% of total variation, clearly separates patients with hepatic implicated diseases from the patients without liver disease and from patients with hypocomplementemia only. The former were characterized by the presence of B8 and C4AQO, the latter by high frequency of C4BQO and B35. Controls are in the centre of the plot.
Considering all the patients (N=39), we found an interesting increase of the frequency of the supposed ancestral haplotype A.H. 35.1 and A.H. 35.3 with respect to the controls: 6.4% (5/78) and 8.89% (7/78) versus 5.05% (9/178) and 0% (0/ 178) respectively.
b) Family analysis
Through family studies it was possible to assess the HLA haplotype configuration and segregation in all of the families studied (N=15). Tab. 3 represents the most frequent HLA haplotypes associated with the hypocomplementemic trait in these families.
We investigated the segregation of the hypocomplementemic trait with the inheritance of HLA haplotypes in the 15 families under study. Transmission disequilibrium test (TDT) showed that the C4BQOalleles were preferentially inherited by affected members [6/7 (87.5%) p=0.065] as well as HLA-B35 [6/6 (100%) p=0.015].
We chose 5 families out of the 15 as the most representative because their progeny consisted of more than one child. Fig.2 shows that in family n Ol the hypocomplementemic trait seems to segregate from the father with the haplotype (a). HLAREGION null alleles were present in this family. In family n03 it was possible to individuate that haplotype (a) carried the hypocomplementemic trait of paternal descent. The proband was affected by hypogammaglobulinemia while his brother was only hypocomplementemic.
In family n05 it was possible to individuate two haplotypes carrying hypocomplementemia, both of maternal descent. The two daughters were only hypocomplementemic, one carrying haplotype (d) and the other carrying haplotype (c). In this family the mother was the proband: she was hypocomplementemic and affected by Raynaud' s syndrome.
In family nOll it was not possible to individuate any haplotype carrying hypocomplementemia. Only the proband was hypocomplementemic and he was affected by C hepatitis.
In family nOl3 it was possible to individuate that haplotype (c) carried the hypocomplementemic trait of maternal descent. The proband was affected by allergic rhinitis By means of linkage analysis we obtained positive LOD Scores only for the HLA class I and IIIloci, although they were not significant (Fig.3) . The highest LOD score (1.44) was obtained for HLA-B locus.
DISCUSSION
The complement system plays a particular role in host defence against infections and is at the same time primarily involved in the inflammatory tissue damage as demonstrated in the classical animal model of immune complex diseases and in human autoimmune pathologies. Therefore, we suggest that the complement has both defensive and pathogenic significance (13) .
The C4 hypocomplementemia is a complex phenomenon that can be due to different factors: the specific and acute consumption of C4; the genetic defect of protein production; in particular the genetic defect can be due to gene deletions or non expression of C4 genes and can be present in a patient in homozygous or heterozygous status. The null C4A allele occurs in about 35% of all SLE patients compared with 10% of the general population (14) . Recently Venneker et al. (15) , observed isolated partial and functional deficiencies of C4 in many family members of a proband with frontoparietal scleroderma. These authors hypothesized that hypocomplementemia can be determined also by a gene not linked to the HLA region.
Our attention is on differing conditions with the common marker ofhypocomplementemia. More recent findings indicate another function of the complement: the activation of the B cells, who proliferate and differentiate in lymphnodes (16) . In fact C3 and C4 in particular have a pivotal role in the inductive phase of antibody response: C3 and C4 have a precise function in B cell priming and are important for a long term antigen retention in vivo (17) . The follicular dendritic cells of lymphoid follicles of spleen or lymphnodes are the sites for antigen presentation to B lymphocytes (18) . A variety of studies have demonstrated that antigen-antibody (Ag-Ab) complexes, recognized by components of classical pathway are trapped by the follicular cells and drive virgin B cells along a specific differentiation pathway.
The amplification, due to complement, of antibody responses in this case acts as interface between innate and adaptive immunity and seems to be an extraordinary important phenomenon. So the complement deficiency could be a main cause of a large cohort of pathologies. It is well known that complement deficiencies (as those of C 1 inhibitor or C2, C3, C4 congenital deficiencies) have significant clinical effects (13) . So it is easy to understand the importance of recognizing the presence of bad functioning complement proteins in many pathologies because it generates an intrinsic unresponsiveness against known or unknown viral agents in the early stage of a disease. Taking all these known phenomena into account, we directed our attention to C4 hypocomplementemia in relation to the biological function of HLA molecules together with C4 expression. In our experience the C4 protein has been proven to be deeply involved in antibody production in hamsters (19) and in humans (20) . In C4-or C3-totally deficient mice it was possible to demonstrate a severe defect in Ab response to thymus dependent antigens, as demonstrated by the reduction of specific splenic follicles and by failure in isotype switching. To possess null alleles is a possible worsening condition: in this study the C4A silent allele seems a marker of hepatopathic conditions (21) ; while the true hypocomplementemia seems due to the absence of C4B protein.
In spite of their above mentioned worsening effects on health, the C4 null alleles are present in certain ancestral haplotypes (AH) in all populations and with a discrete frequency. In Caucasians for instance, the C4BQOallele is present in the following haplotypes: AH18. 2 This was actually the case only for HLA-B35 positive haplotypes and not for the HLA-B44 positive one, suggesting the presence of a worsening gene in linkage disequilibrium with HLA-B35 or a role of HLA-B35 molecule itself in predisposing to immune diseases. This is also corroborated by the evidence of a significantly increased frequency in patients of the supratype AH 35.1 which carries B35 alone and not C4 silent alleles.
HLA class I molecules are presenters, via their external domains, of endogenously derived peptides and control the CD8-mediated cellular response to foreign pathogens. The specificity of recognition and the efficiency of fighting the non-self agents depend on the affinity of the HLA binding site for pathogen peptides and in turn by the amino acid sequences of HLA binding groove. It has been recently proven that a single amino acid substitution in HLA-B35 allele regulates the progression to HIV infection (22) . HLA-B35 positive people and especially those other than HLA-B*3501 are more prone to a rapid evolution of AIDS disease than the others. Furthermore, HLA-B35 has been claimed as predisposing factor for chronic-progressive course ofmultiple sclerosis (23) and for persistence of hepatitis B infection (24) as well as for other pathologies such as Sezary syndrome (25), subacute thyroiditis (26), erythema multiforme (27) .
In this work, mainly through the family study, we envisioned a potentially interesting genomic trait within the HLA, close to B locus, that is involved in hypocomplementemia itself and in hypocomplementemia-related disorders. In particular, TOT test revealed a significant segregation distortion of HLA-B35 suggesting a role of this allele in the evolution of the genetic condition that we broadly termed 'hypocomplementemia'. Finally, due to the familial recurrence of hypocomplementemia, it seems reasonable to check the proband's first degree relatives for complement serum levels as prevention against serious immune pathologies secondary to complement deficiency.
